SRRK — Scholar Rock Holding Corp catalysts
Next verified catalyst
2026-11-01 — Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Tri · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-01 in 1mo
ESTIMATED |
READOUT
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Pr
Phase 3 · Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3 |
SRRK Scholar Rock Holding Corp | Apitegromab |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|
Past
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09-11 9d ago
CONFIRMED |
APPROVED
ISEMBYLD
|
SRRK Scholar Rock Holding Corp | ISEMBYLD |
openFDA (drugsfda) ↗
✓ Source-checked 2026-09-20
Actual/recorded date
|